| Unique ID issued by UMIN | UMIN000060803 |
|---|---|
| Receipt number | R000069563 |
| Scientific Title | Effects of collagen peptide-containing micronutrient supplementation on biochemical indices in hemodialysis patients. |
| Date of disclosure of the study information | 2026/03/04 |
| Last modified on | 2026/03/05 09:29:01 |
Effects of nutritional supplement drink intake on biochemical indicators in dialysis patients.
The effects of nutritional supplements on dialysis patients.
Effects of collagen peptide-containing micronutrient supplementation on biochemical indices in hemodialysis patients.
Effects of nutritional supplement drink intake on biochemical indicators in hemodialysis patients.
| Japan |
Chronic kidney disease (Hemodialysis patients)
| Nephrology |
Others
NO
Hemodialysis therapy, due to its therapeutic characteristics, has been noted to potentially remove not only accumulated uremic toxins and excess fluid from the body, but also trace nutrients and vitamins essential for maintaining biological homeostasis. Deficiencies in these nutrients are implicated in impairing the maintenance of normal biological functions and have been suggested to be associated with worsened prognosis.
This study therefore investigates the actual state of nutrient loss associated with dialysis treatment, the effects of supplementation, and its safety by administering a nutritional supplement beverage containing protein, vitamins, and tracing elements to hemodialysis patients and examining changes in biochemical indicators.
Safety,Efficacy
Blood biochemistry test values before and after intervention.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Food |
Intake of nutritional supplement drink.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1) Patients undergoing maintenance hemodialysis with a nutritional status of moderate or better.
2) Patients with no problems in eating or swallowing function who can independently consume the test food.
3) Patients who understand the explanation given by the person in charge regarding participation in this study and are able to obtain consent to participate in this study of their own volition.
1) Patients for whom obtaining their own expression of intent and consent regarding participation in this study are difficult.
2) Patients with blood test results showing serum albumin levels below 3.0 g/dL.
3) Patients for whom discontinuing consumption of foods that could potentially affect fluctuations in protein and micronutrients due to ingestion of the test food is difficult.
15
| 1st name | Sumihiko |
| Middle name | |
| Last name | Sato |
Medical Corporation Credo Sato Clinic
Department of Nephrology and Dialysis
264-0021
2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture
043-214-3109
ssato@3109jp.com
| 1st name | Takehiro |
| Middle name | |
| Last name | Okama |
Medical Corporation Credo Sato Clinic
Department of Medical Technology
264-0021
2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture
043-214-3109
ookama@3109jp.com
Medical Corporation Credo Sato Clinic
Nutri Co., Ltd.
Profit organization
Sato Clinic Institutional Review Board
2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture
043-214-3109
uchida@3109jp.com
NO
| 2026 | Year | 03 | Month | 04 | Day |
Unpublished
Enrolling by invitation
| 2026 | Year | 02 | Month | 16 | Day |
| 2026 | Year | 02 | Month | 16 | Day |
| 2026 | Year | 03 | Month | 06 | Day |
| 2026 | Year | 07 | Month | 31 | Day |
| 2026 | Year | 03 | Month | 02 | Day |
| 2026 | Year | 03 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069563